Seminars in urologic oncology Journal

Overview

Outcome predictions for patients with metastatic prostate cancer.. 20. 2002
Summary of effect of intravesical bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder (by Harry W. Herr, MD, Carl M. Pinsky, MD, Willet F. Whitmore, Jr, MD, Herbert F. Oettgen, MD, and Myron R. Melamed, MD). 1983.. 15. 1997
Summary of immunohistologic dissection of the human kidney using monoclonal antibodies (by Neil H. Bander, MD, Carlos Cordon-Cardo, MD, PhD, Connie L. Finstad, PhD, Willet F. Whitmore, Jr, MD, E. Darracott Vaughan, Jr, MD, Herbert F. Oettgen, MD, Myron Melamed, MD, and Lloyd J. Old, MD). 1985.. 15. 1997
Adjuvant chemotherapy for stage II nonseminomatous germ-cell tumors. 2002
Chemotherapy for good-risk germ-cell tumors. 2002
The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies. 2002
The utility of monoclonal antibodies in the imaging of prostate cancer. 2002
Prostate biopsy techniques and indications: when, where, and how? 2002
Rising PSAs after primary therapy: active or passive intervention. 1999
High-risk superficial bladder cancer: transurethral resection alone in selected patients with T1 tumor. 1997